| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 08/12/2009 | CN101506182A Single enantiomer beta agonists method for production and use thereof as a medicament |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/06/2009 | WO2009094956A1 A method for preparing 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]-benzoic acid |
| 08/06/2009 | US20090197878 SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR |
| 08/05/2009 | EP2085392A1 Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide |
| 08/05/2009 | EP2084139A2 Oxazolidinium compounds and use as hydrate inhibitors |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/04/2009 | US7569687 Increases yields while reducing the impurity profile of the intermediates and final product; impurities are reduced when 2 mol equivalents of pyrrolidine react with the Compound V; by-product inhibition; elimmmminate unnecessary purification steps; cost efficiency; efficiency |
| 08/04/2009 | US7569564 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy |
| 08/04/2009 | US7569287 Blue electroluminescent polymer and organic electroluminescent device using the same |
| 07/30/2009 | WO2009094169A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 07/30/2009 | WO2009093905A1 Agent for detecting seed viability and a detection method of seed viability using the agent |
| 07/30/2009 | US20090192298 Through-bond energy transfer cassettes, systems and methods |
| 07/30/2009 | US20090192163 Novel Compounds |
| 07/30/2009 | US20090192162 Phenoxy Acetic Acids as PPAR Delta Activators |
| 07/30/2009 | US20090192148 Organic Compounds |
| 07/30/2009 | CA2712500A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 07/29/2009 | EP1461315B1 Catalytic carbonylation of three and four membered heterocycles |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/23/2009 | US20090187017 Process for preparing enantiomerically enriched beta-amino acid derivatives |
| 07/23/2009 | US20090186893 inositol requiring enzyme 1 (IRE-1 alpha) inhibitors such as 2-hydroxy-6-(5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl)-1-naphthaldehyde, relieve protein folding stress by enhancing molecular chaperone activity and protects cells from stress induced apoptosis; autoimmune diseases; anticancer; viricides |
| 07/23/2009 | US20090186882 Cgrp receptor antagonists |
| 07/23/2009 | US20090186881 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/23/2009 | US20090186790 Photo-labile pro-fragrance conjugates |
| 07/23/2009 | DE102008003826A1 Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität Corrosion inhibitors having increased biodegradability and reduced toxicity |
| 07/22/2009 | EP1299354B1 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 07/21/2009 | US7563806 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament |
| 07/16/2009 | WO2009087679A2 Process for preparing polymorphic forms of (s)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2h-3,1-benzoxazin-2-one |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/14/2009 | US7560549 Sulfonyloxy derivatives |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/09/2009 | US20090176786 Benzoylurea Compounds and Use Thereof |
| 07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/08/2009 | EP2076487A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 07/08/2009 | EP2076252A2 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/07/2009 | US7557208 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism |
| 07/07/2009 | US7557207 Spiro 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | WO2009081959A1 Process for production of 4-(substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one |
| 07/02/2009 | WO2009051820A3 Use of oxazine compounds for making chromogenic materials |
| 07/02/2009 | US20090171081 Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
| 07/02/2009 | US20090170813 Hypophosphorous Acid Derivatives and their Therapeutical Applications |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/02/2009 | CA2710485A1 Process for production of 4-(substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one |
| 07/01/2009 | EP2074093A2 Matrix metalloproteinase inhibitors |
| 07/01/2009 | CN100506806C [1.2]-oxazin-3,5-diones |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 06/25/2009 | WO2009077186A1 Nonsteroidal progesterone receptor modulators |
| 06/25/2009 | US20090163711 Process of producing amorolfine base |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163487 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 06/25/2009 | US20090163485 Heteroaryl derivatives as orexin receptor antagonists |
| 06/25/2009 | US20090163472 Mineralocorticoid receptor antagonists and methods of use |
| 06/25/2009 | US20090163457 Compositions and methods for delivering a biologically active agent |
| 06/24/2009 | CN101466686A C-FMS kinase inhibitor |
| 06/24/2009 | CN100503604C Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550459 Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one |
| 06/18/2009 | WO2009076268A1 Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
| 06/18/2009 | WO2009076140A1 Thiazole and oxazole kinase inhibitors |
| 06/18/2009 | WO2009075835A1 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 06/18/2009 | US20090156808 Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof |
| 06/18/2009 | US20090156807 Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone |
| 06/18/2009 | US20090156804 Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| 06/18/2009 | US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors |
| 06/18/2009 | US20090156590 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process for Making Them, and Use Thereof for Treating Pain and Other Conditions |
| 06/18/2009 | US20090156588 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders |
| 06/18/2009 | US20090153039 Green electroluminescent compounds and organic electroluminescent device using the same |
| 06/18/2009 | CA2708303A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | CA2707902A1 Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
| 06/17/2009 | EP2070909A1 Non-steroidal progesterone receptor modulators |
| 06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 06/11/2009 | WO2009071658A1 Piperazines as anti-obesity agents |
| 06/11/2009 | WO2009071252A1 Nonsteroidal progesterone receptor modulators |
| 06/11/2009 | WO2008129004A3 Heterocyclic compounds containing the morpholine nucleus their preparation and use |
| 06/11/2009 | CA2707555A1 Piperazines as anti-obesity agents |
| 06/10/2009 | DE102007058747A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 06/10/2009 | CN101450933A Method for preparing polysubstituted 3,4-dihydro-3-methyl-2H-1,4-benzoxazine-2-one |
| 06/09/2009 | US7544676 Sulfamoyl benzamides and methods of their use |
| 06/04/2009 | WO2009070579A2 Morpholines as selective inhibitors of cytochrome p450 2a13 |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069610A1 Fused indane compound |
| 06/04/2009 | US20090143577 Purification of progesterone receptor modulators |
| 06/04/2009 | US20090143369 Methods of using substituted morpholine and thiomorpholine derivatives |
| 06/04/2009 | CA2706863A1 Morpholines as selective inhibitors of cytochrome p450 2a13 |
| 06/04/2009 | CA2706171A1 Fused indane compound |
| 06/03/2009 | EP2064177A2 Protease inhibitors |
| 06/02/2009 | US7541454 Compounds and methods for fluorescent labeling |
| 06/02/2009 | US7541356 Compounds for use in weight loss and appetite suppression in humans |
| 06/02/2009 | US7541019 diethylenetriaminepentaacetic acid (DTPA) reacted with acetic anhydride in presence of pyridine free of acetionitrile (molar amount of pyridine is equal to or less than 6 times the molar amount of DTPA); chemical intermediate used in the production of drug for therapy and diagnosis |
| 05/28/2009 | US20090137798 Process for the Preparation of Delmopinol and Derivatives Thereof |
| 05/28/2009 | US20090137578 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| 05/28/2009 | US20090137577 Heterocyclic compounds |
| 05/28/2009 | US20090137571 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide;potent openers of the KCNQ family of potassium ion channels; antiepileptic agents;anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 05/28/2009 | US20090137570 Inhibitors of cathepsin s |